Atlas Trials

Aflibercept for Relapsed Multiple Myeloma

Clinical trial NCT00437034 · TERMINATED

Trial details

NCT number
NCT00437034
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage II Multiple MyelomaStage III Multiple Myeloma
Start date
2007-01-01
Primary completion
2010-10-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.